PGU-10628-07089
5 vaccinations
9 coded responses
54 check-ins
9 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 972 / OR
- Registered
- 2021-02-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-06
Registered in v-safe
-
2021-02-06
Dose 1 — Pfizer-BioNTech
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-10
- 2021-02-11
- 2021-02-12
- 2021-02-13
-
2021-02-20
Survey response — day 14, dose 1MedDRA: Fatigue — Feeling: GoodFree text: One day fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-27
Dose 2 — Pfizer-BioNTech
- 2021-02-27
- 2021-02-28
- 2021-03-01
- 2021-03-02
- 2021-03-03
-
2021-03-04
Survey response — days 1–6 daily, dose 2MedDRA: Musculoskeletal stiffness — Feeling: Good · Fever · Chills, Headache, Joint pains, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: StiffnessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-05
- 2021-03-08
- 2021-03-13
- 2021-03-20
-
2021-03-27
Survey response — day 28, dose 2MedDRA: Chills, Fatigue, Pyrexia — Feeling: Good · Be unable to do your normal daily activitiesFree text: One episode of extreme fatigue, followed by chills, then fever. Entire duration was 5 hours or lessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-03
- 2021-04-10
- 2021-05-29
-
2021-08-28
Survey response — 6 months, dose 2MedDRA: Oropharyngeal pain — Feeling: GoodFree text: Sore throatMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-09-27
Dose 3 — Pfizer-BioNTech
- 2021-09-29
-
2021-09-30
Survey response — days 1–6 daily, dose 3MedDRA: Postmenopausal haemorrhage — Feeling: GoodFree text: Post menopausal vaginal bleed. Not heavy, but more than scantMedDRA releases: 2024-11 · check-in free text available
- 2021-10-01
- 2021-10-02
- 2021-10-04
- 2021-10-11
-
2021-10-18
Survey response — day 21, dose 3MedDRA: Breast tenderness — Feeling: GoodFree text: Breast tenderness, first time since menopause, about 10 years agoMedDRA releases: 2024-11 · check-in free text available
- 2021-10-25
- 2021-11-01
- 2021-11-08
-
2021-12-27
Survey response — 3 months, dose 3MedDRA: Office visit, Postmenopausal haemorrhage — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Not exactly new, but developments. Post menopausal bleeding after vaccine, now need pelvic ultrasound & maybe endometrial biopsy. · Healthcare visit (other): Doc visit, ultrasound at lab is scheduledMedDRA releases: 2024-11 · check-in free text available
-
2021-12-27
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professional1 call case(s)
-
2021-12-28
Call successfulDoes not wish to fill out VAERS report
-
2022-03-28
Survey response — 6 months, dose 3MedDRA: Office visit, Uterine disorder — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Continuing uterine (post menopausal) issues. Biopsy negative, but will have a d&c for follow up. · Healthcare visit (other): Primary care consultation, endometrial biopsy, now d&c scheduledMedDRA releases: 2024-11 · check-in free text available
-
2022-03-28
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professional1 call case(s)
- 2022-03-29
-
2022-03-31
Dose 4 — Moderna
- 2022-04-14
- 2022-04-21
- 2022-04-28
-
2022-05-05
Survey response — day 35, dose 4MedDRA: Postmenopausal haemorrhage, Pre-existing disease, Surgery, Uterine dilation and curettage — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Not really new, but did the D&C (surgery) for post menopausal bleeding heightened with earlier booster. Pathology report was normal. · Healthcare visit (other): Outpatient surgeryMedDRA releases: 2024-11 · check-in free text available
-
2022-05-05
Report sent to call center — day 35, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2022-05-06
Call successfulParticipant prefers to complete VAERS report online
- 2022-05-12
- 2022-06-30
-
2022-09-11
Dose 5 — Pfizer-BioNTech
- 2022-09-12
- 2022-09-13
- 2022-09-14
- 2022-09-16
- 2022-09-17
- 2022-09-18
- 2022-09-25
- 2022-10-02
- 2022-10-09
- 2022-10-16
- 2022-10-23
- 2022-12-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-06 | Pfizer-BioNTech | |
| 2 | 2021-02-27 | Pfizer-BioNTech | |
| 3 | 2021-09-27 | Pfizer-BioNTech | No |
| 4 | 2022-03-31 | Moderna | No |
| 5 | 2022-09-11 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-12-27 | Successful 2021-12-28 |
Does not wish to fill out VAERS report |
| 2022-03-28 | Successful | Participant prefers to complete VAERS report online |
| 2022-05-05 | Successful 2022-05-06 |
Participant prefers to complete VAERS report online |
Free text
Release 4 — day 14, dose 1
Symptoms: One day fatigue
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Stiffness
Release 6 — day 28, dose 2
Symptoms: One episode of extreme fatigue, followed by chills, then fever. Entire duration was 5 hours or less
Release 9 — 6 months, dose 2
Symptoms: Sore throat
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Post menopausal vaginal bleed. Not heavy, but more than scant
Release 10 — day 21, dose 3
Symptoms: Breast tenderness, first time since menopause, about 10 years ago
Release 10 — 3 months, dose 3
Symptoms: Not exactly new, but developments. Post menopausal bleeding after vaccine, now need pelvic ultrasound & maybe endometrial biopsy.
Healthcare visit (other): Doc visit, ultrasound at lab is scheduled
Release 11 — 6 months, dose 3
Symptoms: Continuing uterine (post menopausal) issues. Biopsy negative, but will have a d&c for follow up.
Healthcare visit (other): Primary care consultation, endometrial biopsy, now d&c scheduled
Release 11 — day 35, dose 4
Symptoms: Not really new, but did the D&C (surgery) for post menopausal bleeding heightened with earlier booster. Pathology report was normal.
Healthcare visit (other): Outpatient surgery
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| HCVO | Surgery | · | · | ✓ |
| SD | Breast tenderness | · | · | ✓ |
| SD | Chills | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | · | ✓ |
| SD | Postmenopausal haemorrhage | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | Uterine dilation and curettage | · | · | ✓ |
| SD | Uterine disorder | · | · | ✓ |
| SRO | Musculoskeletal stiffness | ✓ | ✓ | ✓ |
| SRO | Postmenopausal haemorrhage | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release